Karyopharm Therapeutics Inc (KPTI) Q2 2020 Earnings Call Transcript

This is Ian Karp and I'm joined today by Dr. Michael Kauffman, Chief Executive Officer; Dr. Sharon Shacham, President and Chief Scientific Officer; Mr. Mike Mason, Chief Financial Officer; Mr. John Demaree, Chief Commercial Officer; and Mr. Christopher Primiano, Chief Business Officer and General Counsel. On the call today, Michael and John will provide an overview of key recent corporate developments and an update on our commercial progress and then Mike Mason will highlight the second quarter 2020 financial results.